Article
Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts…
medRxiv · 2022 · D. Papadopoulou
Key facts
| Title | Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis. |
|---|---|
| First author | D. Papadopoulou |
| Journal | medRxiv |
| Published | Aug 3, 2022 |
| DOI | 10.1101/2022.08.02.500956 |
| Product codes mentioned | JJQ, MVU |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1